Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.6M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
16.1M
-
Shares change
-
+2.27M
-
Total reported value, excl. options
-
$368M
-
Value change
-
+$14.5M
-
Put/Call ratio
-
2.34
-
Number of buys
-
51
-
Number of sells
-
-40
-
Price
-
$22.86
Significant Holders of Neurogene Inc. - Common Stock (NGNE) as of Q4 2024
117 filings reported holding NGNE - Neurogene Inc. - Common Stock as of Q4 2024.
Neurogene Inc. - Common Stock (NGNE) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.1M shares
.
Largest 10 shareholders include Samsara BioCapital, LLC (1.72M shares), BlackRock, Inc. (1.52M shares), RTW INVESTMENTS, LP (1.35M shares), Redmile Group, LLC (1.32M shares), Casdin Capital, LLC (1.3M shares), EcoR1 Capital, LLC (1.27M shares), FMR LLC (860K shares), COMMODORE CAPITAL LP (800K shares), BAKER BROS. ADVISORS LP (674K shares), and VANGUARD GROUP INC (568K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.